| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/27/2007 | US7183399 Nucleotide sequences coding reef coral fluorescent proteins for use as diagnostic tool in genetic engineering |
| 02/27/2007 | US7183397 NK-2 homeobox transcription factor |
| 02/27/2007 | US7183393 Fusion protein of a polypeptide and a heparan sulphate glycosaminoglycan chain which influences binding affinity, binding specificity, and stability; polypeptide of fusion protein can be a cell growth factor, pathogen-related antigen, nuclear protein, cell adhesion molecules, enzyme or enzyme inhibitor |
| 02/27/2007 | US7183390 Humanized antibodies to gamma-interferon |
| 02/27/2007 | US7183389 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 02/27/2007 | US7183388 Anti-MUC-1 single chain antibodies for tumor targeting |
| 02/27/2007 | US7183387 Polypeptide variants with altered effector function |
| 02/27/2007 | US7183386 Coding nucleic acids; binding to antibodies; antiallergens; induce immunology response; diagnosis kit |
| 02/27/2007 | US7183385 Comprises immunoglobulins which bind FMS-related tyrosine kinase 3 (Flt3) receptor for diagnosis and treatment of cancer; immunotherapy |
| 02/27/2007 | US7183384 Such as from breasts, colon, esophagus, liver, lung and ovary tissue cells; fab fragments; hybridoma cell lines; sensitizing tumor cells to cisplatin or doxorubicin by contacting monoclonal antibody which binds extracellular domain of HER2 receptor on the cell |
| 02/27/2007 | US7183379 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/27/2007 | US7183376 Variant B7 co-stimulatory molecules |
| 02/27/2007 | US7183110 Antibody immunoreactive with a 5-enolpyruvylshikimate-3-phosphate synthase |
| 02/27/2007 | US7183094 Detoxification using amylase; drug screening analysis |
| 02/27/2007 | US7183081 Nucleotide sequences coding cytokine polypeptide for use in identifying modulator for treatment or arthritis, allergies, infections, inflammation, skin and cell proliferative disorders; wound healing agents |
| 02/27/2007 | US7183080 Cannie IL-5 nucleic acid molecules |
| 02/27/2007 | US7183078 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 02/27/2007 | US7183076 Method for making multispecific antibodies having heteromultimeric and common components |
| 02/27/2007 | US7183075 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 02/27/2007 | US7183065 Diagnosing ulcerative colitis in humans; obtain sample tissue, incubate with histone antigen, detect presence of complex formation, presence of complex indicates ulcerative colitis |
| 02/27/2007 | US7183063 Can be used in screening for agents which act as antagonists to MCP-1, MIP-1 alpha and/or RANTES |
| 02/27/2007 | US7182946 monoclonal antibody produced by the hybridoma cell line 57D2, deposited in accordance with the Budapest treaty under the number DSM ACC2568, or a fragment of |
| 02/27/2007 | US7182933 Biomolecule carrier bearing molecules that bind to a cellular adhesion molecule expressed on endothelial cell |
| 02/27/2007 | CA2286335C Methods of obtaining antigens specific for fungi, antibodies for such antigens, and diagnosis of disease using such antigens and/or antibodies |
| 02/22/2007 | WO2007022475A1 Fas binding antibodies |
| 02/22/2007 | WO2007022416A2 Single chain antibodies against beta-amyloid peptide |
| 02/22/2007 | WO2007022172A1 Human monoclonal antibodies that specifically bind igf-ii |
| 02/22/2007 | WO2007021841A2 Identification and engineering of antibodies with variant fc regions and methods of using same |
| 02/22/2007 | WO2007021253A1 Compounds and methods for inhibiting hepatitis c virus replication |
| 02/22/2007 | WO2007021129A1 A method for the mass production of immunoglobulin fc region deleted initial methionine residues |
| 02/22/2007 | WO2007021004A1 Msx1/2, MARKERS OF GROWING PROGENITOR CELL OF DOPAMINE-PRODUCING NEURON |
| 02/22/2007 | WO2007021003A1 Nato3, MARKER OF GROWING PROGENITOR CELL OF DOPAMINE-PRODUCING NEURON |
| 02/22/2007 | WO2007021002A1 Immunodetection method for influenza virus h5 subtype |
| 02/22/2007 | WO2007020965A1 Method of inhibiting function of cytosolic protein by single chain antibody and use thereof |
| 02/22/2007 | WO2007020357A2 Method for carrying out homogeneous phase detection, in particular, for detecting the progesterone in the milk of a mammal and corresponding kit |
| 02/22/2007 | WO2007020244A1 The mitochondrial rhomboid protease parl as a target for lymphoma |
| 02/22/2007 | WO2007020243A2 Vaccine based on virus-neutralizing antibodies |
| 02/22/2007 | WO2007019901A1 Food products comprising probiotic micro-organisms and antibodies |
| 02/22/2007 | WO2007019621A1 Chimeric antibodies with new world primate regions |
| 02/22/2007 | WO2007019620A1 Engineered antibodies with new world primate framework regions |
| 02/22/2007 | WO2006138553A3 Methods of purifying fc region containing proteins |
| 02/22/2007 | WO2006125632A3 Agonistic antibodies that bind to the tweak receptor fn14 and thereby modulate adiposity-associated phenotypes as well as their use in therapy |
| 02/22/2007 | WO2006125207A3 Compositions and methods for increasing the stability of antibodies |
| 02/22/2007 | WO2006104911A3 Methods and compositions for modulating hyperstabilized c-met |
| 02/22/2007 | WO2006086638A3 Targeting lipocalin-2 for cancer therapeutics |
| 02/22/2007 | WO2006084050A3 Libraries and methods for isolating antibodies |
| 02/22/2007 | WO2006071441A3 Antibodies directed to gpnmb and uses thereof |
| 02/22/2007 | WO2006069202A3 Compositions comprising anti-igf-i receptor antibodies and methods for obtaining said antibodies |
| 02/22/2007 | WO2006066088A3 Methods for treating autoimmune disorders |
| 02/22/2007 | WO2006063302A3 Variants of glycogen synthase kinase 3 and uses thereof |
| 02/22/2007 | WO2006059108A3 ANTI-IL-IRl SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC USES |
| 02/22/2007 | WO2005121338A9 Anti-perp antibody |
| 02/22/2007 | WO2005042725A3 Liver cancer biomarkers |
| 02/22/2007 | WO2004108748A3 Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses |
| 02/22/2007 | WO2004094467A3 H. pylori antigens |
| 02/22/2007 | WO2004048543A3 Methods and compositions for controlling valency of phage display |
| 02/22/2007 | US20070044175 Genes conferring herbicide resistance |
| 02/22/2007 | US20070044166 P2Y4 Receptor transgenic and knockout non-human mammals |
| 02/22/2007 | US20070043211 Mammalian transforming growth factor beta-9 |
| 02/22/2007 | US20070043210 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 02/22/2007 | US20070043209 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 02/22/2007 | US20070042980 Gp131: methods and compositions for treating cancer |
| 02/22/2007 | US20070042945 Nouvelles compositions et methods de traitement du psoriasis |
| 02/22/2007 | US20070042472 Mammalian transforming growth factor beta-9 |
| 02/22/2007 | US20070042468 Interferon-like protein zcyto21 |
| 02/22/2007 | US20070042466 Il-1 related polypeptides |
| 02/22/2007 | US20070042447 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers (divisional) |
| 02/22/2007 | US20070042446 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 02/22/2007 | US20070042432 Method of diagnosis and treatment |
| 02/22/2007 | US20070042431 Methods for reducing complexity of a sample using small epitope antibodies |
| 02/22/2007 | US20070042420 Liver tumor marker sequences |
| 02/22/2007 | US20070042416 Dendritic Enriched Secreted Lymphocyte Activation Molecule |
| 02/22/2007 | US20070042415 Anti-fused antibodies |
| 02/22/2007 | US20070042385 Novel compositions and methods in cancer |
| 02/22/2007 | US20070042383 for detecting Mycobacterium paratuberculosis in a sample using nucleic acid molecules, polypeptides, and antibodies; for immunization and prevention of mycobacterial animal infections |
| 02/22/2007 | US20070042382 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 02/22/2007 | US20070042374 drug screening; obesity, diabetes mellitus, impaired glucose tolerance, arteriosclerosis, hypertension or hyperlipemia |
| 02/22/2007 | US20070042359 E-protein specific immunoglobulin for use in treatment and prevention of viral infection |
| 02/22/2007 | US20070042047 Vaccines |
| 02/22/2007 | US20070041997 Bacterial virulence factors and uses thereof |
| 02/22/2007 | US20070041991 amino acid sequence proteins or immunogenic fragments, encoded sequence from isolated nucleic acid; for treating infection caused from Babesiidae; diagnostic test for the detection of nucleic acids, antibodies or antigens of the organism; safe, stable, easily scaleable production; veterinary medicine |
| 02/22/2007 | US20070041985 Modulation of the poliovirus receptor function |
| 02/22/2007 | US20070041983 Method for treating tumors using anti-osteopontin antibodies |
| 02/22/2007 | US20070041982 ILT3 binding molecules and uses therefor |
| 02/22/2007 | US20070041980 CA6 antigen-specific cytotoxic conjugate and methods of using the same |
| 02/22/2007 | US20070041978 Bispecific antibody substituting for functional proteins |
| 02/22/2007 | US20070041977 Single-chain antibody acting against 37 kda/67 kda laminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof |
| 02/22/2007 | US20070041976 Treating septic arthritis; Interleukin-4 (IL-4), previously known as B cell stimulating factor |
| 02/22/2007 | US20070041975 Homogeneous preparations of il-28 and il-29 |
| 02/22/2007 | US20070041974 Cytokine zalpha11 ligand antibodies |
| 02/22/2007 | US20070041972 Antibodies and fusion proteins that include engineered constant regions |
| 02/22/2007 | US20070041970 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 02/22/2007 | US20070041969 Apo-2DcR |
| 02/22/2007 | US20070041968 Methods of inducing an immune response |
| 02/22/2007 | US20070041967 Igg fc fragment for a drug carrier and method for the preparation thereof |
| 02/22/2007 | US20070041966 Polypeptides including modified constant regions |
| 02/22/2007 | US20070041965 Novel dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 02/22/2007 | US20070041964 WISP polypeptides and nucleic acids encoding same |
| 02/22/2007 | US20070041963 Human secreted proteins |
| 02/22/2007 | US20070041945 Novel method for down-regulation of amyloid |